• Publications
  • Influence
ILAE Official Report: A practical clinical definition of epilepsy
Epilepsy was defined conceptually in 2005 as a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures. This definition is usually practically applied asExpand
  • 1,907
  • 80
  • PDF
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
The International League Against Epilepsy (ILAE) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following theExpand
  • 1,143
  • 49
  • PDF
ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes
Summary:  Purpose: To assess which antiepileptic medications (AEDs) have the best evidence for long‐term efficacy or effectiveness as initial monotherapy for patients with newly diagnosed orExpand
  • 651
  • 37
  • PDF
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Although no randomized studies have demonstrated a positive impact of therapeutic drug monitoring (TDM) on clinical outcome in epilepsy, evidence from nonrandomized studies and everyday clinicalExpand
  • 698
  • 32
  • PDF
Rufinamide: Clinical pharmacokinetics and concentration–response relationships in patients with epilepsy
Rufinamide is a new, orally active antiepileptic drug (AED), which has been found to be effective in the treatment of partial seizures and drop attacks associated with the Lennox‐Gastaut syndrome.Expand
  • 169
  • 29
Clinically relevant drug interactions with antiepileptic drugs.
  • E. Perucca
  • Medicine
  • British journal of clinical pharmacology
  • 1 March 2006
Some patients with difficult-to-treat epilepsy benefit from combination therapy with two or more antiepileptic drugs (AEDs). Additionally, virtually all epilepsy patients will receive, at some timeExpand
  • 441
  • 28
  • PDF
Pharmacological and Therapeutic Properties of Valproate
Thirty-five years since its introduction into clinical use, valproate (valproic acid) has become the most widely prescribed antiepileptic drug (AED) worldwide. Its pharmacological effects involve aExpand
  • 533
  • 23
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
The purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long‐term efficacy or effectiveness for antiepilepticExpand
  • 440
  • 22
  • PDF
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
The Ninth Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT IX, took place in Sitges, Barcelona from the 15th to 19th of June 2008. Over 300 basic scientists, clinical pharmacologists andExpand
  • 182
  • 22
Epilepsy: new advances
Epilepsy affects 65 million people worldwide and entails a major burden in seizure-related disability, mortality, comorbidities, stigma, and costs. In the past decade, important advances have beenExpand
  • 381
  • 21
  • PDF